The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A window of opportunity trial of atorvastatin in p53-mutant and p53 wild type malignancies.
 
Mohammad Telfah
No Relationships to Disclose
 
Tomoo Iwakuma
No Relationships to Disclose
 
Andres Bur
Travel, Accommodations, Expenses - Intuitive Surgical
 
Lisa Shnayder
Consulting or Advisory Role - Hylapharm
Other Relationship - KLS Martin
 
Terry Tsue
No Relationships to Disclose
 
Mazin Mazin Al-Kasspooles
No Relationships to Disclose
 
John Ashcraft
No Relationships to Disclose
 
Benjamin Martin
No Relationships to Disclose
 
Raed Moh'd Taiseer Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - Amgen
Research Funding - EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Anup Kasi
Research Funding - Halozyme (Inst); TESARO (Inst)
 
Qamar J. Khan
Consulting or Advisory Role - Novartis; pfizer
Research Funding - Novartis
 
Tara L. Lin
Honoraria - Jazz Pharmaceuticals
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bio-Path Holdings, Inc (Inst); Celator (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Imago Pharma (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Mateon Therapeutics (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); Seagen (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Anwaar Saeed
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - AstraZeneca/MedImmune (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Lilly
 
Stephen K. Williamson
Research Funding - Acceleron Pharma (Inst); Aleon Pharma (Inst); Astellas Pharma (Inst); Bayer Health (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Merck Serono (Inst); Nektar (Inst); Novartis (Inst); Pharmacyclics (Inst); Regeneron (Inst); Rogosin Institute (Inst); Sanofi (Inst); Seagen (Inst); Sotio (Inst)
 
Prabhakar Chalise
No Relationships to Disclose
 
Andrew K. Godwin
No Relationships to Disclose
 
Greg Reed
No Relationships to Disclose
 
Sufi Thomas
No Relationships to Disclose
 
Takefumi Komiya
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Merck
 
Joaquina Celebre Baranda
Employment - Halozyme
Stock and Other Ownership Interests - Adaptimmune; Halozyme; Ignyta; Loxo
Research Funding - Novartis